CS logo
small CS logo
Oncology-Hematology Associates, P.A.

Clinton, Maryland, United States
Cancer treatment center in Clinton, Maryland
8926 Woodyard Rd #101, Clinton, MD 20735

About Oncology-Hematology Associates, P.A.


"Today, Maryland Oncology Hematology is the largest independent Medical Oncology and Hematology group in Maryland with 30 physicians practicing in 9 locations across central Maryland. Dedicated to providing the most advanced cancer care available anywhere in an atmosphere of caring compassion."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Novartis Pharmaceuticals
2
Pharmatech Oncology
2
Accelerated Community Oncology Research Network
1
Agendia
1
Calithera Biosciences, Inc
1
Daiichi Sankyo, Inc.
1
Eli Lilly and Company
1
G1 Therapeutics, Inc.
1
GRAIL, LLC
1
Gilead Sciences
1
Medsearch
1
Total Rows: 15

Clinical Trials at Oncology-Hematology Associates, P.A.


During the past decade, Oncology-Hematology Associates, P.A. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122000000441100000000000000Started TrialsCompleted Trails20162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
2000-03-01
Unknown status
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2001-07-01
2005-04-01
Completed
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
2000-12-01
2003-06-01
Completed
Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
2001-12-01
Unknown status
Non-small Cell Lung Cancer Registry
2004-11-01
2007-11-01
Completed
300
A Multiple Myeloma Trial in Patients With Bone Metastases
2004-10-01
2007-10-01
Completed
179
Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
2006-07-01
2011-03-01
Terminated
32
Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
2007-06-01
2013-03-01
Completed
502

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology-Hematology Associates, P.A." #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Pharmatech Oncology" with 2 trials sponsored, "Accelerated Community Oncology Research Network" with 1 trials sponsored, "Agendia" with 1 trials sponsored and "Calithera Biosciences, Inc" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology-Hematology Associates, P.A." #1 collaborator was "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNovartis Pharmaceuticals: 2Novartis Pharmaceuticals: 2Pharmatech Oncology: 2Pharmatech Oncology: 2Accelerated CommunityOncology ResearchNetwork: 1Accelerated CommunityOncology ResearchNetwork: 1Agendia: 1Agendia: 1Calithera Biosciences, Inc: 1Calithera Biosciences, Inc: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Eli Lilly and Company: 1Eli Lilly and Company: 1G1 Therapeutics, Inc.: 1G1 Therapeutics, Inc.: 1GRAIL, LLC: 1GRAIL, LLC: 1Gilead Sciences: 1Gilead Sciences: 1

Created with Highcharts 11.1.0Top CollaboratorsMillenniumPharmaceuticals, Inc.: 1MillenniumPharmaceuticals, Inc.: 1

Clinical Trials Conditions at Oncology-Hematology Associates, P.A.


According to Clinical.Site data, the most researched conditions in "Oncology-Hematology Associates, P.A." are "Breast Cancer" (3 trials), "Multiple Myeloma" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Oncology-Hematology Associates, P.A." in a lesser frequency.

Clinical Trials Intervention Types at Oncology-Hematology Associates, P.A.


Most popular intervention types in "Oncology-Hematology Associates, P.A." are "Drug" (12 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "gemcitabine hydrochloride" (2 trials), "zoledronic acid" (2 trials), "Abemaciclib" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology-Hematology Associates, P.A.


The vast majority of trials in "Oncology-Hematology Associates, P.A." are 16 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Oncology-Hematology Associates, P.A.


Currently, there are NaN active trials in "Oncology-Hematology Associates, P.A.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Oncology-Hematology Associates, P.A., undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology-Hematology Associates, P.A., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 3Phase 2: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Terminated: 2Terminated: 2Unknown status: 2Unknown status: 2